Elevated serum vitamin D levels are linked with higher skin cancer risk, finds study Dr. Kamal Kant Kohli3 Sept 2025 8:30 PM ISTSkin cancer, the most common global malignancy, is linked to ultraviolet (UV)-driven serum 25-hydroxyvitamin D (25(OH)D)synthesis, with its...
India faces rising cancer burden, Bengaluru Women Most Affected: Study Anshika Mishra3 Sept 2025 5:30 PM ISTA large cross-sectional study has revealed significant regional disparities in cancer incidence across India and an overall rising cancer burden. The...
Health Bulletin 03/September/2025 Anshika Mishra3 Sept 2025 5:02 PM ISTHere are the top health stories of the day:Kerala HC issues draft guidelines for Medical Negligence CasesThe Kerala High Court recently passed a...
Combination therapy improves outcomes for advanced triple-negative breast cancer: Study Dr. Kamal Kant Kohli2 Sept 2025 9:15 PM IST A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard...
Sepsis can kill even previously healthy people if recognized too late, finds study Dr. Kamal Kant Kohli1 Sept 2025 8:00 AM ISTA recent study University of Michigan led study finds that ten percent of patients hospitalized with sepsis were previously healthy-and many of those...
Medical Bulletin 30/August/2025 Anshika Mishra30 Aug 2025 3:00 PM ISTHere are the top medical news for the day:WHO-Endorsed Mosquito Repellent Cuts Malaria Risk by Over 50%: StudyA recent international study published...
New Research Reveals Diabetes May Accelerate Breast Cancer Growth Anshika Mishra30 Aug 2025 8:15 AM ISTA recent study published in Communications Biology by researchers at Boston University's Chobanian & Avedisian School of Medicine has revealed...
Medical Bulletin 29/August/2025 Dr. Bhumika Maikhuri29 Aug 2025 3:00 PM ISTHere are the top medical news for the day:High-Protein Diet May Raise Risk of Cancer-Associated Venous Thromboembolism: StudyA new study by...
AstraZeneca Imfinzi application granted priority review by USFDA for resectable early stage gastric, gastroesophageal junction cancers Ruchika Sharma29 Aug 2025 10:30 AM ISTCambridge: AstraZeneca has announced that its supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has been accepted...
